Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
Strategies and innovations related to how clinical professionals are utilizing technology internal and external to their organizations to advance clinical trials. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
Pharsight Expands Global Presence Through InforSense Chinese Distributor, Companies to Collaborate On Use of Biomarkers in PK/PD Modeling
MOUNTAIN VIEW, Calif., and LONDON, Oct. 7, 2008 (GLOBE NEWSWIRE)—
As part of the agreement, InforSense will represent Pharsight's market-leading software for pharmacokinetic and pharmacodynamic (PK/PD)
Pharsight and InforSense have also initiated a strategic partnership to deliver translational research solutions to the pharmaceutical industry. The strategic partnership includes opportunities for product-based collaborations to utilize biomarkers in clinical PK/PD modeling.
"This agreement strengthens Pharsight's ability to take advantage of the exceptional growth opportunities in China as research and
"Pharsight's tools are a fundamental requirement in PK/PD, particularly in the pharmaceutical industry, and we are pleased to be working with
To initiate the partnership, Pharsight will participate at several events sponsored by InforSense in Shanghai, China on November 3-5,
More information about this event is available at www.drugdiscovery-china.cn.
About InforSense, Ltd.
InforSense goes beyond traditional business intelligence to provide a completely integrated suite of agile, visual and predictive intelligence solutions, enabling organizations to gain business and scientific insights and optimize their business-critical decision-making processes. Leading pharmaceutical, biotechnology, consumer goods, healthcare, financial services, manufacturing and communications companies around the world rely on InforSense to quickly, easily deliver intelligence and identify trends in data. The company is privately held, with European headquarters in London, UK and North American headquarters in Cambridge, Massachusetts. For more information visit www.inforsense.com.
About Pharsight Corporation
Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. The company's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.
Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight
Forward Looking Statements
The statements in this press release related to the performance of Pharsight software products in China and Pharsight's strategic partnership with InforSense Ltd. are forward-looking statements. Forward-looking statements are inherently speculative, and actual results may differ materially from Pharsight's expectations due to a variety of factors, including: changes in FDA regulations may affect demand for the product and services; and customers may not perceive the benefits of the products and services to be the same as Pharsight believes them to be. Other risk factors relating to Pharsight are disclosed in the company's most recent Form 10-K filed with the Securities and Exchange Commission on August 13, 2008. All
Registered Trademarks and Trademarks
Pharsight and WinNonlin are registered trademarks of Pharsight Corporation. InforSense and the InforSense logo are registered trademarks of InforSense Limited. All other brand or product names mentioned in this document are trademarks or registered trademarks of their respective companies or organizations.